Finding an association of ANGPTL4 variants with triglyceride levels in T2D, particularly if modifiable by a lifestyle intervention, would have important implications for personalized approaches to the treatment of T2D and cardiovascular disease. The gene discussed is ANGPTL4; the disease is type 2 diabetes mellitus.